Details of the Drug Reposition

General Information of This Drug (ID: DMUAZWG)

Drug Name
Leucovorin   DMUAZWG
Synonyms 5-formyltetrahydrofolate; Citrovorum factor; Folinic acid
Therapeutic Class
Vitamins
Drug Type
Small molecular drug
Structure
3D MOL 2D MOL

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
4 Approved Indication(s)
Indication Name Indication ID ICD-11 Status REF
Rectum mucinous adenocarcinoma DIS75WFS N.A. Approved [1]
Colon adenocarcinoma DISDRE0J N.A. Approved [1]
Rectal adenocarcinoma DIS8R9VO 2B92 Approved [1]
Pervasive developmental disorder DIS51975 6A00-6A0Z Approved [1]
------------------------------------------------------------------------------------
1 Discontinued in Phase 2 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Rectal signet ring cell adenocarcinoma DISORL5H N.A. Discontinued in Phase 2 [2]
------------------------------------------------------------------------------------
4 Investigative Indication(s)
Indication Name Indication ID ICD-11 Status REF
Methotrexate toxicity DISU9Z8R N.A. Investigative [1]
Megaloblastic anemia DISVIZPC N.A. Investigative [1]
Colon mucinous adenocarcinoma DISXZXEI N.A. Investigative [1]
Colon cancer DISVC52G 2B90.Z Investigative [1]
------------------------------------------------------------------------------------

References

1 Leucovorin FDA Label
2 Lenalidomide With or Without Rituximab in Treating Patients With Progressive or Relapsed Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Prolymphocytic Leukemia, or Non-Hodgkin Lymphoma Previously Treated With Donor Stem Cell Transplant